ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

ORGS Orgenesis Inc

0.527
-0.016 (-2.95%)
04 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Orgenesis Inc ORGS 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
-0.016 -2.95% 0.527 05:30:00
개장가 저가 고가 종가 전일 종가
0.547 0.505 0.5796 0.527 0.543
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
16/04/202406:07GLOBEOrgenesis Provides Year End Business Update
11/04/202401:00GLOBEGermfree and Orgenesis Announce Asset Purchase and Strategic..
18/03/202421:30GLOBEVered Caplan, CEO of Orgenesis, to Present at the..
13/03/202421:30GLOBEOrgenesis Consortium Awarded €1.5M EUR Grant from the..
04/03/202422:30GLOBEOrgenesis Inc. Announces $2.3 Million Private Placement
29/02/202422:30GLOBEOrgenesis Consortium Awarded €2.0M EUR Grant from Walloon..
31/01/202423:20EDGAR2Form 8-K - Current report
31/01/202423:15GLOBEOrgenesis Acquires Control of Octomera with the Goal of..
25/01/202406:05EDGAR2Form 8-K - Current report
23/01/202406:01EDGAR2Form 8-K - Current report
09/01/202407:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/01/202407:36EDGAR2Form 3 - Initial statement of beneficial ownership of..
05/01/202420:02EDGAR2Form 8-K - Current report
14/11/202322:30GLOBEOrgenesis Ranked No. 171st Fastest-Growing Company in North..
14/11/202306:15GLOBEOrgenesis Provides Business Update for the Third Quarter of..
09/11/202321:41EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
08/11/202323:24EDGAR2Form 8-K - Current report
08/11/202323:00GLOBEOrgenesis Inc. Announces Pricing of $1.1 Million Registered..
02/11/202321:00GLOBEOrgenesis Announces Expanded Partnership Between Octomera..
31/10/202310:30GLOBEOrgenesis Announces Withdrawal of Proposed Public Offering
31/10/202305:07GLOBEOrgenesis Announces Proposed Underwritten Public Offering
21/09/202321:00GLOBECGT Global and Octomera Enter Agreement to Expand Cell &..
06/09/202320:00GLOBECell and Gene Therapy Industry Pioneer & GMP Expert, Gerhard..
06/09/202305:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/08/202320:00GLOBEOrgenesis Provides Business Update for Second Quarter of..
11/08/202306:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/08/202321:30GLOBEOrgenesis Schedules Second Quarter 2023 Business Update..
13/07/202321:30GLOBEOrgenesis Appoints Finance Veteran Elliot Maltz as its Chief..
13/07/202305:05EDGAR2Form 8-K - Current report
11/07/202320:00GLOBEOrgenesis Announces Name Change of Morgenesis Business Unit..
07/06/202320:00GLOBEOrgenesis and University of California, Davis Sign..
30/05/202322:30GLOBEClaudia Zylberberg Appointed as Independent Board Member of..
22/05/202320:30GLOBEOrgenesis Academy Graduates First Class of Cell and Gene..
19/05/202321:30GLOBEOrgenesis to Participate in Benchmark’s 3rd Annual..
18/05/202320:30GLOBEOrgenesis Announces Collaboration Agreement with SCTbio to..
11/05/202305:30GLOBEOrgenesis Provides Business Update for the First Quarter of..
10/05/202323:00GLOBEOrgenesis Secures an Additional $5 Million Investment from..

최근 히스토리

Delayed Upgrade Clock